| Leah Kaufman, MD | |
|
725 Irving Ave, Ste 600, Syracuse, NY 13210-1603 | |
| (315) 464-5162 | |
| (315) 464-4613 |
| Full Name | Leah Kaufman |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 26 Years |
| Location | 725 Irving Ave, Syracuse, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033289483 | NPI | - | NPPES |
| 02286822 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 216176 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Suny/stony Brook University Hospital | Stony brook, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Associates In Obstetrics And Gynecology University Faculty | 9032001045 | 93 |
News Archive
A common polymorphism - a variation in a person's DNA sequence that is found with regularity in the general population - can lead to a chain of events that dictates how a tumor will progress in certain types of cancer, including a form of breast cancer as well as ovarian cancer, according to new research from The Wistar Institute that was published online by the journal Cancer Cell.
Pfizer has announced that it has received a request for additional information from the U.S. Federal Trade Commission ("FTC") with respect to its previously announced proposed acquisition of Wyeth.
According to a new study hormone therapy may not be as risky for elder women as earlier thought. This comes from the Women's Health Initiative, a federally funded trial that tracked thousands of women taking hormones or placebo pills for years. The WHI looked at women who have had hysterectomies or have had their uterus removed and thus can take estrogen unaccompanied by another hormone, progestin. It found that a heightened risk of stroke from taking estrogen faded with time, while a reduced risk of breast cancer held steady.
US-Australian drug discovery company, Novogen Ltd, and its subsidiary, CanTx, Inc., and Yale University, on March 27 released pre-clinical data on experimental anti-cancer drug, Cantrixil. The data was presented as an oral presentation by Professor Gil Mor MD PhD of Yale Medical School to the 62nd Annual Scientific Meeting of the Society of Reproductive Investigation in San Francisco, CA.
› Verified 6 days ago
| Entity Name | University Associates In Obstetrics & Gynecology University Faculty P |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538114723 PECOS PAC ID: 9032001045 Enrollment ID: O20040325001243 |
News Archive
A common polymorphism - a variation in a person's DNA sequence that is found with regularity in the general population - can lead to a chain of events that dictates how a tumor will progress in certain types of cancer, including a form of breast cancer as well as ovarian cancer, according to new research from The Wistar Institute that was published online by the journal Cancer Cell.
Pfizer has announced that it has received a request for additional information from the U.S. Federal Trade Commission ("FTC") with respect to its previously announced proposed acquisition of Wyeth.
According to a new study hormone therapy may not be as risky for elder women as earlier thought. This comes from the Women's Health Initiative, a federally funded trial that tracked thousands of women taking hormones or placebo pills for years. The WHI looked at women who have had hysterectomies or have had their uterus removed and thus can take estrogen unaccompanied by another hormone, progestin. It found that a heightened risk of stroke from taking estrogen faded with time, while a reduced risk of breast cancer held steady.
US-Australian drug discovery company, Novogen Ltd, and its subsidiary, CanTx, Inc., and Yale University, on March 27 released pre-clinical data on experimental anti-cancer drug, Cantrixil. The data was presented as an oral presentation by Professor Gil Mor MD PhD of Yale Medical School to the 62nd Annual Scientific Meeting of the Society of Reproductive Investigation in San Francisco, CA.
› Verified 6 days ago
| Entity Name | University Ob/gyn Associates, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235170150 PECOS PAC ID: 9133117740 Enrollment ID: O20040503001562 |
News Archive
A common polymorphism - a variation in a person's DNA sequence that is found with regularity in the general population - can lead to a chain of events that dictates how a tumor will progress in certain types of cancer, including a form of breast cancer as well as ovarian cancer, according to new research from The Wistar Institute that was published online by the journal Cancer Cell.
Pfizer has announced that it has received a request for additional information from the U.S. Federal Trade Commission ("FTC") with respect to its previously announced proposed acquisition of Wyeth.
According to a new study hormone therapy may not be as risky for elder women as earlier thought. This comes from the Women's Health Initiative, a federally funded trial that tracked thousands of women taking hormones or placebo pills for years. The WHI looked at women who have had hysterectomies or have had their uterus removed and thus can take estrogen unaccompanied by another hormone, progestin. It found that a heightened risk of stroke from taking estrogen faded with time, while a reduced risk of breast cancer held steady.
US-Australian drug discovery company, Novogen Ltd, and its subsidiary, CanTx, Inc., and Yale University, on March 27 released pre-clinical data on experimental anti-cancer drug, Cantrixil. The data was presented as an oral presentation by Professor Gil Mor MD PhD of Yale Medical School to the 62nd Annual Scientific Meeting of the Society of Reproductive Investigation in San Francisco, CA.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leah Kaufman, MD 725 Irving Ave, Ste 600, Syracuse, NY 13210-1603 Ph: (315) 464-5162 | Leah Kaufman, MD 725 Irving Ave, Ste 600, Syracuse, NY 13210-1603 Ph: (315) 464-5162 |
News Archive
A common polymorphism - a variation in a person's DNA sequence that is found with regularity in the general population - can lead to a chain of events that dictates how a tumor will progress in certain types of cancer, including a form of breast cancer as well as ovarian cancer, according to new research from The Wistar Institute that was published online by the journal Cancer Cell.
Pfizer has announced that it has received a request for additional information from the U.S. Federal Trade Commission ("FTC") with respect to its previously announced proposed acquisition of Wyeth.
According to a new study hormone therapy may not be as risky for elder women as earlier thought. This comes from the Women's Health Initiative, a federally funded trial that tracked thousands of women taking hormones or placebo pills for years. The WHI looked at women who have had hysterectomies or have had their uterus removed and thus can take estrogen unaccompanied by another hormone, progestin. It found that a heightened risk of stroke from taking estrogen faded with time, while a reduced risk of breast cancer held steady.
US-Australian drug discovery company, Novogen Ltd, and its subsidiary, CanTx, Inc., and Yale University, on March 27 released pre-clinical data on experimental anti-cancer drug, Cantrixil. The data was presented as an oral presentation by Professor Gil Mor MD PhD of Yale Medical School to the 62nd Annual Scientific Meeting of the Society of Reproductive Investigation in San Francisco, CA.
› Verified 6 days ago
Kasandra Lynne Scales, MD, MPH Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-5162 Fax: 315-464-4613 | |
Alfredo Lopez, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 516 Prospect Ave, Syracuse, NY 13208 Phone: 315-703-5200 Fax: 315-703-5201 | |
Althea Hoilett Barrett, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 330 Palace Ct, Apt. C, Syracuse, NY 13212 Phone: 315-836-3012 | |
George L Stanley, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 819 S Salina St, Syracuse, NY 13202 Phone: 315-476-7921 Fax: 315-474-1448 | |
Carly Hornis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 739 Irving Ave, Suite 530, Syracuse, NY 13210 Phone: 315-478-1158 Fax: 315-478-3014 | |
Mr. Dimitrios S Mastrogiannis, MD,PHD,FACOG Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 90 Presidential Plaza, 3rd Fl, Syracuse, NY 13202 Phone: 315-464-4458 Fax: 315-464-6388 |